Tumor Ablation Market Expected to Reach $7.5 Billion by 2035

According to a new report published by Allied Market Research, titled, “Tumor Ablation Market," The tumor ablation market size was valued at $1.6 billion in 2023, and is estimated to reach $7.5 billion by 2035, growing at a CAGR of 13.6% from 2024 to 2035.

Tumor ablation is a medical procedure used to treat cancer by destroying tumor tissue using various techniques. It involves the targeted destruction of abnormal cells without the need for traditional surgery. Common methods of tumor ablation include radiofrequency ablation (RFA), microwave ablation, cryoablation, and laser ablation. Each method utilizes different energy forms, such as heat, cold, or radiation, to directly destroy the tumor or shrink it. Tumor ablation is often used for tumors that are difficult to remove surgically, located in sensitive areas, or in patients who may not be suitable candidates for surgery. The procedure is done percutaneously, laparoscopically, or during surgical procedures, depending on the tumor's location and size.

According to tumor ablation market forecast analysis the major factors that drive the global tumor ablation market include the continuous evolution of ablation technologies, rise in number of cancer cases, and surge in public awareness about cancer prevention, early detection, & treatment options. Innovations in energy-based techniques such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and laser ablation have revolutionized the treatment of tumors. These technologies offer significant advantages over traditional surgical methods, such as smaller incisions, reduced complications, shorter recovery times, and less pain.

The development of newer, more efficient devices with enhanced precision and safety profiles further supports market expansion. In addition, the integration of image-guided technologies, such as ultrasound, CT scans, and MRI, helps ensure greater accuracy in targeting tumors, which is essential for achieving effective outcomes. Thus, the techological advancement in the laser hair removal is expected to drive the tumor ablation market growth.

Furthermore, according to tumor ablation market trends analysis countries in Asia-Pacific and LAMEA have experienced rapid improvements in their healthcare systems, which include better access to advanced medical treatments and technologies. These regions have witnessed a rise in healthcare investments, which increased the availability of tumor ablation therapies to a broader population. As more healthcare facilities adopt modern treatment technologies and expand their services, the market for tumor ablation is expected to grow at a faster rate in these regions. However, the high cost of ablation devices and procedures, particularly in low-income regions, along with the risks of complications such as damage to surrounding tissues and the potential for tumor recurrence, are factors which hinder growth of tumor ablation industry.

According to tumor ablation market opportunity analysis factors such as expanding healthcare infrastructure in emerging markets, increased awareness about cancer treatments, and rise in technological advancements provide an opportunity for market growth. The tumor ablation market is classified on the basis of technology, treatment, application, and region. Depending on the technology, the market is classified into radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other ablation technologies. The radiofrequency ablation segment dominated the market share in 2023.

This was attributed to the widespread adoption of radiofrequency ablation devices, high efficacy in treating various tumors, and cost-effectiveness compared to other ablation techniques. Its minimally invasive nature, combined with technological advancements and surge in its preference among healthcare providers, contributed to its leadership in the market share. However, the microwave ablation segment is expected to register the highest CAGR during the forecast period. This is attributed to its ability to deliver faster and more precise energy for tumor destruction, making it effective for larger and multiple tumors.

Technological advancements improving efficiency and safety, along with growing adoption of microwave ablation in treating challenging cancer cases, also contribute to tumor ablation market growth. Depending on the treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. The percutaneous ablation segment dominated the tumor ablation market share in 2023. This was attributed to its ability to treat larger tumors more effectively, deliver uniform heat distribution, and minimize procedural time. 

In addition, increase in adoption of advanced imaging technologies for precision guidance and surge in demand for minimally invasive cancer therapies further contribute to the growth of this segment. However, laparoscopic ablation segment is expected to register the highest CAGR during the forecast period. This is attributed to its ability to provide precise tumor targeting through minimally invasive techniques. This approach reduces recovery time, minimizes complications, and enhances patient outcomes compared to open surgeries. Increase in adoption of advanced laparoscopic instruments and growing awareness of its benefits among healthcare professionals and patients are key factors driving tumor ablation market size.

Depending on the application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, bone cancer, and others. The liver cancer segment dominated the tumor ablation market share in 2023. This was attributed to the rise in prevalence of liver cancer and the increasing demand for minimally invasive treatment options. Tumor ablation techniques are particularly effective for liver cancer, as they provide targeted therapy for inoperable tumors. Advancements in imaging technologies and ablation devices further enhance treatment precision, contributing to the segment's significant market share.

However, the kidney cancer segment is expected to register the highest CAGR during the forecast period. This is attributed to the increase in prevalence of renal tumors and the growing adoption of minimally invasive treatments such as tumor ablation. Improved diagnostic capabilities, advancements in ablation technologies, and rising awareness of early detection contribute to the demand for effective kidney cancer therapies.

Region wise, North America was the largest shareholder in the global tumor ablation industry in 2023, owing to its advanced healthcare infrastructure, high adoption of innovative ablation technologies, and surge in prevalence of cancer in the region. The presence of key market players and supportive government initiatives for cancer research further boosted the market growth in the region. In addition, increase in awareness of tumor ablation techniques and demand for minimally invasive procedures contributed to North America's leadership.

However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period owing to its rapidly improving healthcare infrastructure, increase in prevalence of cancer, and rising awareness of advanced treatment options such as tumor ablation. In addition, the region's large population base, coupled with growing investments in healthcare and the adoption of minimally invasive technologies, further supports market growth in the region.

Key Findings of The Study

• By technology, the radiofrequency ablation segment was the highest contributor to the market in 2023.
• By treatment, the laparoscopic ablation segment was the highest contributor to the market in 2023.
• By application, the liver cancer segment was the highest contributor to the market in 2023.
• By region, North America garnered the largest revenue share in 2023. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period.